{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:11:29Z","timestamp":1791882689516,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068617-15"],"award-info":[{"award-number":["UM1AI068617-15"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30 MH058107"],"award-info":[{"award-number":["P30 MH058107"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R34 DA059327"],"award-info":[{"award-number":["R34 DA059327"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CRC-2021-00132"],"award-info":[{"award-number":["CRC-2021-00132"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral Pre-exposure prophylaxis (PrEP) is effective in preventing HIV transmission. However, despite high rates of HIV risk behaviors among people who inject drugs (PWID), this population remains underserved by current HIV prevention efforts in the United States. To address this challenge, we conducted an in-depth exploration of perspectives on using oral PrEP among PWID engaged in the HIV Prevention Trials Network (HPTN) 094 INTEGRA Study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Guided by the Practical, Robust, Implementation, and Sustainability Model (PRISM), our qualitative study drew on semi-structured interviews conducted as part of the embedded implementation science evaluation of HPTN 094 INTEGRA. Seventy-seven PWID participants from five sites across New York City, Houston, Los Angeles, Philadelphia, and Washington DC were interviewed to assess intervention delivery, care access, and engagement sustainability. Audio files were transcribed verbatim and analyzed via an inductive and deductive thematic approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most participants (<jats:italic>n<\/jats:italic>\u2009=\u200946, 59.7%) discussed oral PrEP during their interview, though not directly prompted. Participants discussing PrEP had a mean age of 41.6 years and were predominantly white (54.3%) and cisgender men (60.9%). Among these, 15 participants described using PrEP. All participants had facilitated access to oral PrEP. Yet, the choice to use PrEP was influenced by personal risk perceptions, (mis)information about PrEP, and external factors (i.e. housing, financial security), which, for some, limited the autonomy to use PrEP. Two key themes emerged among participants using PrEP: ease of access and perceptions of high HIV risk. Those not using PrEP described two themes: low risk perception and prioritizing more urgent needs. Among participants not using PrEP a subgroup commonly described ambivalent interest, PrEP knowledge gaps, and PrEP readiness (i.e., contemplation).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Qualitative findings highlight that facilitated PrEP access was insufficient to motivate use for many participants. Rather, PrEP decision-making process (i.e., choice) was linked to risk perception and individuals\u2019 capability to leverage PrEP as a resource based on their circumstances (i.e., autonomy). Participants\u2019 descriptions of the centrality of choice and autonomy for PrEP use underscore that ease of access is a necessary pre-condition, but person-centered interventions should also address housing, financial stability, and urgent medical conditions to promote PrEP utilization among PWID.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical trial registration<\/jats:title>\n                <jats:p>NCT04804027.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-024-00520-3","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:36:26Z","timestamp":1734510986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Centering autonomy and choice to support oral PrEP utilization among people who inject drugs: qualitative lessons from HPTN 094 INTEGRA"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-4358","authenticated-orcid":false,"given":"Amaya","family":"Perez-Brumer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan E.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda R.","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"El-Bassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Shoptaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laramie R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"520_CR1","unstructured":"Centers for Disease Control and Prevention. Preexposure Prophylaxis for the prevention of HIV infection in ihe United States \u2013 2021 Update A Clinical Practice Guideline [Internet]. 2021. http:\/\/www.file:\/\/\/Users\/aperebrumer\/Downloads\/cdc-hiv-prep-guidelines-2021.pdf"},{"key":"520_CR2","unstructured":"HIV Diagnoses | HIV in the US | HIV Statistics Center | HIV | CDC [Internet]. 2023 [cited 2023 Aug 3]. https:\/\/www.cdc.gov\/hiv\/statistics\/overview\/in-us\/diagnoses.html"},{"issue":"1","key":"520_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12889-018-6314-8","volume":"19","author":"AR Bazzi","year":"2019","unstructured":"Bazzi AR, Drainoni ML, Biancarelli DL, Hartman JJ, Mimiaga MJ, Mayer KH, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019;19(1):31.","journal-title":"BMC Public Health"},{"issue":"2","key":"520_CR4","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/S2352-3018(16)30207-7","volume":"4","author":"M Martin","year":"2017","unstructured":"Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock PA, Chaipung B, et al. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study. Lancet HIV. 2017;4(2):e59\u201366.","journal-title":"Lancet HIV"},{"issue":"1","key":"520_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/QAI.0000000000002407","volume":"85","author":"CN Okafor","year":"2020","unstructured":"Okafor CN, Hucks-Ortiz C, Hightow-Weidman LB, Magnus M, Emel L, Beauchamp G, et al. Brief report: associations between Self-reported Substance Use behaviors and PrEP Acceptance and Adherence among Black MSM in the HPTN 073 study. J Acquir Immune Defic Syndr. 2020;85(1):23\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2\u20133","key":"520_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.10.014","volume":"88","author":"J Ahern","year":"2007","unstructured":"Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2\u20133):188\u201396.","journal-title":"Drug Alcohol Depend"},{"key":"520_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310.","journal-title":"Int J Drug Policy"},{"key":"520_CR8","doi-asserted-by":"publisher","first-page":"103112","DOI":"10.1016\/j.drugpo.2021.103112","volume":"93","author":"BE Meyerson","year":"2021","unstructured":"Meyerson BE, Russell DM, Kichler M, Atkin T, Fox G, Coles HB. I don\u2019t even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. Int J Drug Policy. 2021;93:103112.","journal-title":"Int J Drug Policy"},{"key":"520_CR9","doi-asserted-by":"publisher","first-page":"215013192110639","DOI":"10.1177\/21501319211063999","volume":"13","author":"B Pleuhs","year":"2022","unstructured":"Pleuhs B, Mistler CB, Quinn KG, Dickson-Gomez J, Walsh JL, Petroll AE, et al. Evidence of potential discriminatory HIV Pre-exposure Prophylaxis (PrEP) prescribing practices for people who inject drugs among a small percentage of providers in the U.S. J Prim Care Community Health. 2022;13:21501319211063999.","journal-title":"J Prim Care Community Health"},{"issue":"4","key":"520_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s11606-022-07672-5","volume":"38","author":"AR Bazzi","year":"2023","unstructured":"Bazzi AR, Shaw LC, Biello KB, Vahey S, Brody JK. Patient and provider perspectives on a Novel, low-threshold HIV PrEP Program for people who inject drugs experiencing homelessness. J GEN INTERN MED. 2023;38(4):913\u201321.","journal-title":"J GEN INTERN MED"},{"issue":"4","key":"520_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s10461-021-03488-2","volume":"26","author":"SM Walters","year":"2022","unstructured":"Walters SM, Frank D, Van Ham B, Jaiswal J, Muncan B, Earnshaw V, et al. PrEP care Continuum Engagement among persons who inject drugs: rural and urban differences in Stigma and Social Infrastructure. AIDS Behav. 2022;26(4):1308\u201320.","journal-title":"AIDS Behav"},{"issue":"6","key":"520_CR12","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s10461-024-04308-z","volume":"28","author":"B Suprasert","year":"2024","unstructured":"Suprasert B, Tate M, Reagan D, Ruiz R, Gao K, McNaughton K, et al. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among people who inject drugs (PWID), San Francisco, 2022. AIDS Behav. 2024;28(6):2089\u2013100.","journal-title":"AIDS Behav"},{"issue":"8","key":"520_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/09564624231154302","volume":"34","author":"HC Spencer","year":"2023","unstructured":"Spencer HC, Babiarz J, Menza TW. Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon. Int J STD AIDS. 2023;34(8):567\u201373.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"520_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/08897077.2019.1675118","volume":"40","author":"JL Taylor","year":"2019","unstructured":"Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: Hiv exposure Prophylaxis in the highest risk people who inject drugs. Substance Abuse. 2019;40(4):441\u20133.","journal-title":"Substance Abuse"},{"issue":"12","key":"520_CR15","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3201\/eid2412.180400","volume":"24","author":"M Hoenigl","year":"2018","unstructured":"Hoenigl M, Jain S, Moore D, Collins D, Sun X, Anderson PL, et al. Substance use and adherence to HIV Preexposure Prophylaxis for men who have sex with Men1. Emerg Infect Dis. 2018;24(12):2292\u2013302.","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"520_CR16","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","volume":"321","author":"R Chou","year":"2019","unstructured":"Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al. Preexposure Prophylaxis for the Prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214\u201330.","journal-title":"JAMA"},{"issue":"4","key":"520_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1071\/SH18228","volume":"16","author":"P Read","year":"2019","unstructured":"Read P, Chronister KJ, Kostovski C, Harrod ME, Salmon A, Jauncey M. Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia. Sex Health. 2019;16(4):383\u20138.","journal-title":"Sex Health"},{"issue":"1","key":"520_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12954-022-00721-6","volume":"19","author":"TS Bartholomew","year":"2022","unstructured":"Bartholomew TS, Andraka-Cristou B, Totaram RK, Harris S, Doblecki-Lewis S, Ostrer L, et al. We want everything in a one-stop shop: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for black people who inject drugs. Harm Reduct J. 2022;19(1):133.","journal-title":"Harm Reduct J"},{"issue":"1","key":"520_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","volume":"15","author":"KB Biello","year":"2018","unstructured":"Biello KB, Bazzi AR, Mimiaga MJ, Biancarelli DL, Edeza A, Salhaney P, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15(1):55.","journal-title":"Harm Reduct J"},{"issue":"5","key":"520_CR20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","volume":"25","author":"CB Mistler","year":"2021","unstructured":"Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure Prophylaxis (PrEP) Care Cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490\u2013506.","journal-title":"AIDS Behav"},{"key":"520_CR21","doi-asserted-by":"publisher","first-page":"115886","DOI":"10.1016\/j.socscimed.2023.115886","volume":"324","author":"T Fleming","year":"2023","unstructured":"Fleming T, Collins AB, Boyd J, Knight KR, McNeil R. It\u2019s no foundation, there\u2019s no stabilization, you\u2019re just scattered: a qualitative study of the institutional circuit of recently-evicted people who use drugs. Soc Sci Med. 2023;324:115886.","journal-title":"Soc Sci Med"},{"issue":"6","key":"520_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.15288\/jsad.2020.81.740","volume":"81","author":"KE Schneider","year":"2020","unstructured":"Schneider KE, White RH, Musci RJ, O\u2019Rourke A, Kilkenny ME, Sherman SG, et al. The Relationship between Polysubstance Injection Drug Use, HIV Risk behaviors, and interest in Pre-exposure Prophylaxis (PrEP) among people who inject drugs in Rural West Virginia. J Stud Alcohol Drugs. 2020;81(6):740\u20139.","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"520_CR23","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1186\/s12889-020-09883-z","volume":"20","author":"PA Shuper","year":"2020","unstructured":"Shuper PA, Joharchi N, Bogoch II, Loutfy M, Crouzat F, El-Helou P, et al. Alcohol consumption, substance use, and depression in relation to HIV Pre-exposure Prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men. BMC Public Health. 2020;20(1):1782.","journal-title":"BMC Public Health"},{"issue":"4","key":"520_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/OLQ.0000000000000728","volume":"45","author":"AM Roth","year":"2018","unstructured":"Roth AM, Aumaier BL, Felsher MA, Welles SL, Martinez-Donate AP, Chavis M, et al. An exploration of factors impacting preexposure Prophylaxis Eligibility and Access among Syringe Exchange users. Sex Transm Dis. 2018;45(4):217\u201321.","journal-title":"Sex Transm Dis"},{"key":"520_CR25","doi-asserted-by":"publisher","first-page":"113809","DOI":"10.1016\/j.socscimed.2021.113809","volume":"275","author":"M Felsher","year":"2021","unstructured":"Felsher M, Ziegler E, Amico KR, Carrico A, Coleman J, Roth AM. PrEP just isn\u2019t my priority: adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA. Soc Sci Med. 2021;275:113809.","journal-title":"Soc Sci Med"},{"issue":"8","key":"520_CR26","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1016\/S2352-3018(17)30073-5","volume":"4","author":"K DeBeck","year":"2017","unstructured":"DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, Sherman S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357\u201374.","journal-title":"Lancet HIV"},{"issue":"1","key":"520_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/apc.2009.0242","volume":"24","author":"MF Batkis","year":"2010","unstructured":"Batkis MF, Treisman GJ, Angelino AF. Integrated Opioid Use Disorder and HIV Treatment: Rationale, Clinical guidelines for Addiction Treatment, and review of interactions of Antiretroviral agents and Opioid Agonist therapies. AIDS Patient Care STDs. 2010;24(1):15\u201322.","journal-title":"AIDS Patient Care STDs"},{"issue":"Supplement 2","key":"520_CR28","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1097\/QAI.0000000000000628","volume":"69","author":"N El-Bassel","year":"2015","unstructured":"El-Bassel N, Strathdee SA. Women who use or inject drugs: an Action Agenda for Women-Specific, Multilevel, and Combination HIV Prevention and Research. JAIDS J Acquir Immune Defic Syndr. 2015;69(Supplement 2):S182\u201390.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"520_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11904-019-00436-7","volume":"16","author":"L Fanucchi","year":"2019","unstructured":"Fanucchi L, Springer SA, Korthuis PT. Medications for treatment of opioid use disorder among persons living with HIV. Curr HIV\/AIDS Rep. 2019;16(1):1\u20136.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"520_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","volume":"14","author":"SM Walters","year":"2017","unstructured":"Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14(1):40.","journal-title":"Harm Reduct J"},{"issue":"4","key":"520_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/09540121.2022.2031853","volume":"35","author":"ESG Massey","year":"2023","unstructured":"Massey ESG, Bazzi AR, Sian CR, Gebel CM, Bernstein JA, Assoumou SA. I\u2019ve been 95% safe: perspectives on HIV pre-exposure prophylaxis at a drug detoxification center: a qualitative study. AIDS Care. 2023;35(4):461\u20135.","journal-title":"AIDS Care"},{"issue":"4","key":"520_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11904-021-00556-z","volume":"18","author":"KB Biello","year":"2021","unstructured":"Biello KB, Mimiaga MJ, Valente PK, Saxena N, Bazzi AR. The past, Present, and future of PrEP implementation among people who use drugs. Curr HIV\/AIDS Rep. 2021;18(4):328\u201338.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"520_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12954-019-0347-x","volume":"16","author":"RM Pinto","year":"2019","unstructured":"Pinto RM, Chen Y, Park SE. A client-centered relational framework on barriers to the integration of HIV and substance use services: a systematic review. Harm Reduct J. 2019;16(1):71.","journal-title":"Harm Reduct J"},{"issue":"4","key":"520_CR34","first-page":"228","volume":"34","author":"AC Feldstein","year":"2008","unstructured":"Feldstein AC, Glasgow RE, Practical A. Robust implementation and sustainability model (PRISM) for integrating Research findings into Practice. Joint Comm J Qual Patient Saf. 2008;34(4):228\u201343.","journal-title":"Joint Comm J Qual Patient Saf"},{"issue":"1","key":"520_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s43058-021-00174-1","volume":"2","author":"S Ramanadhan","year":"2021","unstructured":"Ramanadhan S, Revette AC, Lee RM, Aveling EL. Pragmatic approaches to analyzing qualitative data for implementation science: an introduction. Implement Sci Commun. 2021;2(1):70.","journal-title":"Implement Sci Commun"},{"issue":"6","key":"520_CR36","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10508-020-01684-0","volume":"49","author":"M Felsher","year":"2020","unstructured":"Felsher M, Ziegler E, Smith LR, Sherman SG, Amico KR, Fox R, et al. An exploration of pre-exposure Prophylaxis (PrEP) initiation among women who inject drugs. Arch Sex Behav. 2020;49(6):2205\u201312.","journal-title":"Arch Sex Behav"},{"issue":"1","key":"520_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70.","journal-title":"Harm Reduct J"},{"issue":"4","key":"520_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10728-020-00412-y","volume":"28","author":"N Stoljar","year":"2020","unstructured":"Stoljar N. Disgust or dignity? The Moral basis of harm reduction. Health Care Anal. 2020;28(4):343\u201351.","journal-title":"Health Care Anal"},{"issue":"1","key":"520_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1089\/apc.2022.0139","volume":"37","author":"DT Boyd","year":"2023","unstructured":"Boyd DT, Nelson LE, Hill MJ, Whitfield D, Ramos SR, Akyirem S, et al. Examining the role of autonomy support, goal setting, and Care Coordination Quality on HIV PrEP Adherence in Black men who have sex with men: HPTN 073. AIDS Patient Care STDs. 2023;37(1):22\u201330.","journal-title":"AIDS Patient Care STDs"},{"issue":"6","key":"520_CR40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11524-022-00666-y","volume":"99","author":"LE Nelson","year":"2022","unstructured":"Nelson LE, Boyd DT, Beauchamp G, Emel L, Wilton L, Whitfield D, et al. Freedom as Prevention: mechanisms of autonomy support for promoting HIV Pre-exposure Prophylaxis Use and Condom Use among Black MSM in 3 US Cities\u2014HPTN 073. J Urban Health. 2022;99(6):1157\u201369.","journal-title":"J Urban Health"},{"issue":"3","key":"520_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12160-009-9090-y","volume":"37","author":"GC Williams","year":"2009","unstructured":"Williams GC, Niemiec CP, Patrick H, Ryan RM, Deci EL. The importance of supporting autonomy and perceived competence in facilitating long-term tobacco abstinence. Ann Behav Med. 2009;37(3):315\u201324.","journal-title":"Ann Behav Med"},{"issue":"5","key":"520_CR42","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure Prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778\u2013811.","journal-title":"Adv Ther"},{"issue":"1","key":"520_CR43","doi-asserted-by":"publisher","first-page":"21092","DOI":"10.7448\/IAS.19.1.21092","volume":"19","author":"RG Parker","year":"2016","unstructured":"Parker RG, Perez-Brumer A, Garcia J, Gavigan K, Ramirez A, Milnor J, et al. Prevention literacy: community-based advocacy for access and ownership of the HIV prevention toolkit. J Int AIDS Soc. 2016;19(1):21092.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"520_CR44","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1007\/s10461-021-03312-x","volume":"25","author":"M Felsher","year":"2021","unstructured":"Felsher M, Dutra K, Monseur B, Roth AM, Latkin C, Falade-Nwulia O. The influence of PrEP-Related Stigma and Social Support on PrEP-Use Disclosure among women who inject drugs and Social Network members. AIDS Behav. 2021;25(12):3922\u201332.","journal-title":"AIDS Behav"},{"issue":"2","key":"520_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11904-018-0385-0","volume":"15","author":"SA Golub","year":"2018","unstructured":"Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV\/AIDS Rep. 2018;15(2):190\u20137.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"520_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/JAN.0000000000000522","volume":"34","author":"JD Champion","year":"2023","unstructured":"Champion JD, Recto P. An Assessment of HIV Risk, perceptions of risk, and potential adherence to Preexposure Prophylaxis among HIV-Negative people with Injection Drug Use who Access Mobile Outreach services. J Addictions Nurs. 2023;34(2):101.","journal-title":"J Addictions Nurs"},{"issue":"2","key":"520_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5334\/ijic.7636","volume":"23","author":"D Kurpas","year":"2023","unstructured":"Kurpas D, Mendive JM, Vidal-Alaball J, Petrazzuoli F, Morad M, Kloppe T, et al. European perspective on How Social Prescribing Can Facilitate Health and Social Integrated Care in the community. Int J Integr Care. 2023;23(2):13.","journal-title":"Int J Integr Care"},{"key":"520_CR48","unstructured":"Pollard T, Gibson K, Griffith B, Jeffries J, Moffatt S. Implementation and impact of a social prescribing intervention: an ethnographic exploration. Br J Gen Pract [Internet]. 2023 May 5 [cited 2023 Aug 4]; https:\/\/bjgp.org\/content\/early\/2023\/07\/10\/BJGP.2022.0638"},{"issue":"12","key":"520_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/apc.2018.0126","volume":"32","author":"AR Bazzi","year":"2018","unstructured":"Bazzi AR, Biancarelli DL, Childs E, Drainoni ML, Edeza A, Salhaney P, et al. Limited knowledge and mixed interest in Pre-exposure Prophylaxis for HIV Prevention among people who inject drugs. AIDS Patient Care STDS. 2018;32(12):529\u201337.","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"520_CR50","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.amepre.2020.09.011","volume":"60","author":"JJ Earlywine","year":"2021","unstructured":"Earlywine JJ, Bazzi AR, Biello KB, Klevens RM. High prevalence of indications for pre-exposure Prophylaxis among people who inject drugs in Boston, Massachusetts. Am J Prev Med. 2021;60(3):369\u201378.","journal-title":"Am J Prev Med"},{"issue":"5","key":"520_CR51","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1007\/s10461-024-04285-3","volume":"28","author":"WH Eger","year":"2024","unstructured":"Eger WH, Bazzi AR, Valasek CJ, Vera CF, Harvey-Vera A, Artamonova I, et al. Long-acting Injectable PrEP interest and general PrEP awareness among people who inject drugs in the San Diego-Tijuana Border Metroplex. AIDS Behav. 2024;28(5):1650\u201361.","journal-title":"AIDS Behav"},{"issue":"7","key":"520_CR52","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/apc.2022.0068","volume":"36","author":"AR Bazzi","year":"2022","unstructured":"Bazzi AR, Valasek CJ, Streuli SA, Vera CF, Harvey-Vera A, Philbin MM, et al. Long-acting Injectable Human Immunodeficiency Virus Pre-exposure Prophylaxis Preferred Over other modalities among people who inject drugs: findings from a qualitative study in California. AIDS Patient Care STDs. 2022;36(7):254\u201362.","journal-title":"AIDS Patient Care STDs"},{"key":"520_CR53","doi-asserted-by":"publisher","unstructured":"Dangerfield DT, Davis G, Pandian V, Anderson JN. Using Motivational Interviewing to Increase HIV PrEP Initiation and Adherence: a Scoping Review. Prev Sci [Internet]. 2023 May 30 [cited 2023 Aug 4]; https:\/\/doi.org\/10.1007\/s11121-023-01554-w","DOI":"10.1007\/s11121-023-01554-w"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-024-00520-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:10:25Z","timestamp":1734516625000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-024-00520-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1186\/s13722-024-00520-3","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved for all sites by a central institutional review board (Advarra), and specific to the implementation science sub-study University of Toronto Research Ethics Board approval was also obtained. All participants provide written informed consent prior to initiation of any study activities. This manuscript\u2019s content is solely the author\u2019s responsibility and does not necessarily represent the official views of the NIH. JEL has receives research support from Gilead Sciences and Zydus and is a consultant to CytoDyn and Theratechnologies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}